Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival

Christian Ewelt(University of Münster), Michael Sabel(Düsseldorf University Hospital), Marion Rapp(Düsseldorf University Hospital), Hans‐Jakob Steiger, Mathias Goeppert(Heinrich Heine University Düsseldorf), Walter Stummer(University of Münster)
Journal of Neuro-Oncology
October 15, 2010
10.1007/s11060-010-0429-9
Cited by 149

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
|Neurosurgery|2015|368